An interventional study of Internal jugular vein CVC insertion in Central Line-associated Bloodstream Infection (CLABSI), Central Venous Catheter Associated Bloodstream Infection and Heart; Surgery, Heart, Functional Disturbance as Result, sponsored by IRCCS Policlinico S. Donato. Withdrawn at 1 site in Italy. Open to participants aged Up to 1 Year. Per ClinicalTrials.gov, last updated 2023-11-18.
Sponsored by IRCCS Policlinico S. Donato · Not applicable, Interventional, and Prevention
Randomized controlled trial comparing femoral vs internal jugular insertion site of central venous catheters (CVC) in newborns and infants undergoing cardiac surgery. The experimental hypothesis is that the jugular insertion site is superior to the femoral in terms of catheter colonization.
Background: in adult patients, the femoral site of insertion of CVC is notoriously at higher risk of colonization and central-line associated bloodstream infection (CLABSI) than other sites (jugular or subclavian). In pediatric patients, the femoral site is more commonly used than in adult patients, but there is no sound data on catheter colonization and CLABSI related to the insertion site. The experimental hypothesis of this randomized controlled trial (RCT) is that the jugular insertion site is less likely to induce catheter colonization and CLABSI than the femoral site.
Methods: 160 patients under 1 year and scheduled for cardiac surgery will be included in this RCT; patients will be randomly allocated to the jugular (J Group) or Femoral (F Group). CVC insertion will be performed by one out of three selected expert operators.
The primary endpoint is the catheter colonization based on identification of bacterial grow into the catheter at removal time; CLABSI and CRBSI rate based on the same bacterial identification into the catheter tip and in the blood culture performed in case of signs and symptoms of infection.
Secondary endpoints are mechanical complications defined as arterial puncture immediately identified during procedure, hemothorax and pneumothorax; and procedural difficulty during insertion defined as number of attempts, no guidewire progress, duration of the procedure (time from the completion of the sterile precaution barriers and the catheter fixation.
Planned cardiac surgery Age \<1 year Eligibility for both insertion sites (jugular and femoral) for CVC Availability of at least one out of the three chosen expert operators
Exclusion Criteria:
Emergency surgery Known vascular anatomic anomalies Previous cardiac surgery in the last 6 months No expert operator availability Intensive Care unit before surgery Central venous catheter inside at the time of randomization
Withdraw criteria (only for the first endpoint):
Impossibility to placement catheter in the selected site.
CVC insertion in the left or right internal jugular vein
Procedure: Internal jugular vein CVC insertion
CVC insertion in the right or left femoral vein
Procedure: Internal jugular vein CVC insertion
Double lumen CVC insertion in the internal jugular vein
CVC colonization
CVC positive culture after removal
Time frame: 14 days
CRBSI
Positive CVC culture and blood stream infection for the same organism
Time frame: 14 days
CLABSI
A laboratory-confirmed bloodstream infection where central line was in place for more than 48h.
Time frame: More than 48 hours
Mechanical complications
Defined as arterial puncture; hemothorax; pneumothorax
Time frame: 1 day
Procedural difficulty
Defined by number of attempts; no guidewire progress
Time frame: 1 hour
Plan to share: Yes — The dataset will be made available at reasonable request
Supporting information: Study protocol, Sap
This study is withdrawn, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Policlinico S. Donato